| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.07▲ | 1.08▼ | 1.08▼ | 1.03▲ | 0.99▲ |
| MA10 | 1.07▲ | 1.08▼ | 1.10▼ | 0.97▲ | 1.12▼ |
| MA20 | 1.07▲ | 1.10▼ | 1.09▼ | 0.97▲ | 1.11▼ |
| MA50 | 1.08▼ | 1.06▲ | 0.99▲ | 1.12▼ | 1.36▼ |
| MA100 | 1.10▼ | 0.98▲ | 0.97▲ | 1.11▼ | 0.96▲ |
| MA200 | 1.08▼ | 0.97▲ | 1.01▲ | 1.26▼ | 1.38▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.008▼ | -0.011▼ | 0.029▲ | -0.018▼ |
| RSI | 48.376▼ | 46.845▼ | 56.691▲ | 54.591▲ | 47.965▼ |
| STOCH | 33.333 | 14.293▼ | 11.584▼ | 58.815 | 12.996▼ |
| WILL %R | -50.000 | -91.667▼ | -92.857▼ | -25.926 | -77.273▼ |
| CCI | 44.444 | -83.710 | -103.968▼ | 155.813▲ | -68.128 |
|
Thursday, August 06, 2026 01:16 PM
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition”), today reported financial ...
|
|
Thursday, August 06, 2026 01:15 PM
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition”), today reported financial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 1.10 | 1.12 | 1.065 | 1.08 | 900,758 |
| 06/08/26 | 1.10 | 1.15 | 1.08 | 1.13 | 1,036,702 |
| 05/08/26 | 0.9899 | 1.07 | 0.9526 | 1.06 | 653,667 |
| 04/08/26 | 0.9015 | 1.02 | 0.8957 | 0.9861 | 724,037 |
| 03/08/26 | 0.90 | 0.9199 | 0.8802 | 0.8915 | 314,467 |
| 31/07/26 | 0.934 | 0.9398 | 0.8881 | 0.8896 | 395,128 |
| 30/07/26 | 0.8952 | 0.93 | 0.8899 | 0.916 | 248,737 |
| 29/07/26 | 0.924 | 0.9399 | 0.88 | 0.9011 | 335,126 |
| 28/07/26 | 0.95 | 0.95 | 0.8801 | 0.9235 | 471,265 |
| 27/07/26 | 0.94 | 0.9738 | 0.9119 | 0.9494 | 400,420 |
|
|
||||
|
|
||||
|
|